Search Result "Rv3790 (DprE1)"
DprE1 - from the Discovery to the Promising Tuberculosis Drug Target
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 2 Year: 2014 Page: 4379-4403
Author(s): Katarina Miku sova, Vadim Makarov, Joao Neres
Decaprenylphosphoryl-β-D-Ribose 2-Epimerase from Mycobacterium tuberculosis is a Magic Drug Target
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 3099-3108
Author(s): G. Manina, M. R. Pasca, S. Buroni, E. De Rossi, G. Riccardi
4H-1,3-Benzothiazin-4-one a Promising Class Against MDR/XDR-TB
Journal: Current Topics in Medicinal Chemistry
Volume: 19 Issue: 8 Year: 2019 Page: 567-578
Author(s): Marcus Vinicius Nora de Souza,Thais Cristina Mendonça Nogueira
Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors
Journal: Current Topics in Medicinal Chemistry
Volume: 21 Issue: 21 Year: 2021 Page: 1922-1942
Author(s): Sisir Nandi,Anil Kumar Saxena
Synthesis and Biological Activity of 2-Amino- and 2-aryl (Heteryl) Substituted 1,3-Benzothiazin-4-ones
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 19 Issue: 12 Year: 2019 Page: 999-1014
Author(s): Emiliya V. Nosova,Galina N. Lipunova,Valery N. Charushin,Oleg N. Chupakhin
Tuberculosis Clinical Trial Update and the Current Anti-Tuberculosis Drug Portfolio
Journal: Current Medicinal Chemistry
Volume: 20 Issue: 30 Year: 2013 Page: 3785-3796
Author(s): Juan Carlos Palomino,Anandi Martin
Filling the Pipeline - New Drugs for an Old Disease
Journal: Current Topics in Medicinal Chemistry
Volume: 14 Issue: 1 Year: 2014 Page: 110-129
Author(s): Matthias Stehr,Ayssar A. Elamin,Mahavir Singh
Key Targets and Relevant Inhibitors for the Drug Discovery of Tuberculosis
Journal: Current Drug Targets
Volume: 14 Issue: 6 Year: 2013 Page: 676-699
Author(s): Xiuming Xiong, Zhijian Xu, Zhuo Yang, Yingtao Liu, Di Wang, Mei Dong, Emily J. Parker, Weiliang Zhu